RenaissanceRe Holdings (NYSE: RNR) CFO sells 5,000 shares
Rhea-AI Filing Summary
RenaissanceRe Holdings Ltd executive vice president and CFO Robert Qutub reported selling a total of 5,000 shares of common stock on July 28, 2026, in three open-market transactions at weighted-average prices of $332.1600, $333.2300 and $334.1000 per share, with individual trade prices ranging from $331.55 to $334.42.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Insider Trade Summary
Net Seller: 5,000 shares
Net Sell
3 txns
Insider
Qutub Robert
Role
EVP, Chief Financial Officer
Sold
5,000 shs ($1.67M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1 | 1,582 | $332.16 | $525K |
| Sale | Common Stock F2 | 2,640 | $333.23 | $880K |
| Sale | Common Stock F3 | 778 | $334.10 | $260K |
Holdings After Transaction:
Common Stock — 72,907 shares (Direct)
Footnotes (3)
- F1. Represents a weighted average price. The shares were sold in multiple transactions at prices ranged from $331.55 to $332.51. The reporting person undertakes to provide the full information regarding the number of shares sold at each price to the Commission, the issuer or a security holder of the issuer upon request.
- F2. Represents a weighted average price. The shares were sold in multiple transactions at prices ranged from $332.6622 to $333.5887. The reporting person undertakes to provide the full information regarding the number of shares sold at each price to the Commission, the issuer or a security holder of the issuer upon request.
- F3. Represents a weighted average price. The shares were sold in multiple transactions at prices ranged from $333.78 to $334.42. The reporting person undertakes to provide the full information regarding the number of shares sold at each price to the Commission, the issuer or a security holder of the issuer upon request.
Key Figures
Common shares sold: 5,000 shares
First tranche shares: 1,582 shares
First tranche weighted-average price: $332.1600 per share
+4 more
7 metrics
Common shares sold
5,000 shares
Total common stock sold by CFO Robert Qutub on July 28, 2026
First tranche shares
1,582 shares
First reported common stock sale tranche on July 28, 2026
First tranche weighted-average price
$332.1600 per share
Weighted-average price for 1,582-share sale; individual prices $331.55–$332.51
Second tranche shares
2,640 shares
Second reported common stock sale tranche on July 28, 2026
Second tranche weighted-average price
$333.2300 per share
Weighted-average price for 2,640-share sale; prices $332.6622–$333.5887
Third tranche shares
778 shares
Third reported common stock sale tranche on July 28, 2026
Third tranche weighted-average price
$334.1000 per share
Weighted-average price for 778-share sale; prices $333.78–$334.42
Key Terms
weighted average price, open market or private transaction, non-derivative
3 terms
weighted average price financial
"Represents a weighted average price. The shares were sold"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
open market or private transaction financial
"Sale in open market or private transaction"
non-derivative financial
"transaction_type is non-derivative common stock"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider stock activity did RenaissanceRe (RNR) report for CFO Robert Qutub?
RenaissanceRe (RNR) reported that CFO Robert Qutub sold 5,000 shares of common stock. The sales occurred in three separate open-market transactions on July 28, 2026, all reported as non-derivative dispositions at weighted-average prices around $332–$334 per share.
Were Robert Qutub’s RenaissanceRe (RNR) stock sales under a Rule 10b5-1 plan?
The Form 4 does not indicate that CFO Robert Qutub’s sales were made under a Rule 10b5-1 trading plan. The document-level Rule 10b5-1 checkbox is not selected, and the footnotes only describe weighted-average pricing and execution price ranges.
Did RenaissanceRe (RNR) CFO Robert Qutub trade derivatives or common stock?
CFO Robert Qutub traded non-derivative common stock of RenaissanceRe (RNR). All three reported transactions are classified as non-derivative dispositions of common stock, with no related derivative exercises or option conversions disclosed in this Form 4 filing.